Philippe Jacquerye results 2
· Newest (Page 1/1, per page 25)
Author: Philippe Jacquerye ×Clear All Filters
Search Results
Background Safinamide is a recent multimodal antiparkinsonian drug that inhibits monoamine oxidase B and modulates the glutamatergic system with positive effects on motor and nonmotor symptoms of Parkinson’s disease (PD). This post-hoc analysis of the European SYNAPSES study provides first-time data on the use of safinamide in routine clinical practice in Belgium. Objective To describe the efficacy and safety of safinamide in...
Previous1Next